- Home
- SUNS vs SEER Comparison
SUNS vs SEER Comparison
Compare SUNS & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNS
- SEER
- Stock Information
- Founded
- SUNS 2023
- SEER 2017
- Country
- SUNS United States
- SEER United States
- Employees
- SUNS N/A
- SEER N/A
- Industry
- SUNS Real Estate Investment Trusts
- SEER Medicinal Chemicals and Botanical Products
- Sector
- SUNS Real Estate
- SEER Health Care
- Exchange
- SUNS Nasdaq
- SEER Nasdaq
- Market Cap
- SUNS 128.7M
- SEER 113.8M
- IPO Year
- SUNS N/A
- SEER 2020
- Fundamental
- Price
- SUNS $9.62
- SEER $1.98
- Analyst Decision
- SUNS Strong Buy
- SEER
- Analyst Count
- SUNS 3
- SEER 0
- Target Price
- SUNS $13.50
- SEER N/A
- AVG Volume (30 Days)
- SUNS 51.0K
- SEER 128.9K
- Earning Date
- SUNS 11-13-2025
- SEER 11-06-2025
- Dividend Yield
- SUNS 12.51%
- SEER N/A
- EPS Growth
- SUNS 1112.46
- SEER N/A
- EPS
- SUNS 1.09
- SEER N/A
- Revenue
- SUNS $19,384,703.00
- SEER $16,376,999.00
- Revenue This Year
- SUNS $183.25
- SEER $25.97
- Revenue Next Year
- SUNS $62.46
- SEER $24.00
- P/E Ratio
- SUNS $8.79
- SEER N/A
- Revenue Growth
- SUNS 2540.16
- SEER 12.11
- 52 Week Low
- SUNS $7.80
- SEER $1.62
- 52 Week High
- SUNS $15.70
- SEER $2.63
- Technical
- Relative Strength Index (RSI)
- SUNS 48.39
- SEER 34.36
- Support Level
- SUNS $9.36
- SEER $2.05
- Resistance Level
- SUNS $9.77
- SEER $2.07
- Average True Range (ATR)
- SUNS 0.32
- SEER 0.08
- MACD
- SUNS 0.04
- SEER -0.02
- Stochastic Oscillator
- SUNS 54.93
- SEER 23.08
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.